Home >> Archive >> Vol:1, No:3 >> Clinical Importance of Botulinum Toxin Applications in Cervical Dystonia

Clinical Importance of Botulinum Toxin Applications in Cervical Dystonia

| Ayşe Gül Kabakcı | | Melike Gizem Kalaycı | | Memduha Gülhal Bozkır |

Year:2022| Vol:1| No:3| PP 104-122
Abstract
Objective: To compile and reveal the clinical importance of botulinum toxin applications in cervical dystonia. Materials and Methods: When we searched the PUBMED database with the keywords ”cervical dystonia botox”, 472 studies were obtained and 104 publications were found when clinical studies were selected. Results: While 38 of the 472 studies in the literature belong to the last ten years, when the options for accessing the full text were filtered, 181 studies were carried out in the last 10 years and the full text of 56 of them could be accessed. Only 9 of these are clinical trials. When the full-text clinical study was selected, 17 studies were obtained, 9 of which were conducted in the last ten years. Conclusion: Cervical dystonia is one of the most common application areas of botox apart from cosmetic use. There are not many studies on physiotherapy in cervical dystonia yet. As a result of the literature review, we think that although botulinum toxin is one of the best treatment options for cervical dystonia, adding physiotherapy to the treatment process will yield better results.

Keywords
Botox; Botulinum toxin; Cervical dystonia
Full Paper (PDF)

Rights and permissions
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References
  1. Baysal, V. and Yildirim, M. Botulinum toxin and use in dermatology. In TURKDERM-Turkish Archives of Dermatology and Venereology, 36 (2): 92-96, 2002.
  2. ÇOcSKUN, ". and YILMAZ ALTINTAcS, N. Orofasial B"olgede Botulinum Toksin Uygulamalari. In Firat "Universitesi Sauglik Bilimleri Tip Dergisi, 30 (1): 43-49, 2016.
  3. Majid, OW Clinical use of botulinum toxins in oral and maxillofacial surgery. In International journal of oral and maxillofacial surgery, 39 (3): 197-207, 2010.
  4. Erbguth, F. J and Naumann, M. Historical aspects of botulinum toxin: Justinus Kerner (1786--1862) and the “sausage poison”. In Neurology, 53 (8): 1850-1850, 1999.
  5. Tinastepe, N.; K"uç"uk, B. B. and Oral, K. Botulinum toxin for the treatment of bruxism. In CRANIOtextregistered, 33 (4): 292-299, 2015.
  6. Moore, P. and Naumann, M. Handbook of botulinum toxin treatment. Wiley-Blackwell, 2003.
  7. Turton, K.; Chaddock, J. A and Acharya, K R. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. In Trends in biochemical sciences, 27 (11): 552-558, 2002.
  8. Rossetto, O.; Seveso, M.; Caccin, P.; Schiavo, G. and Montecucco, C. Tetanus and botulinum neurotoxins: turning bad guys into good by research. In Toxicon, 39 (1): 27-41, 2001.
  9. Aoki, K R. Pharmacology and immunology of botulinum toxin serotypes. In Journal of Neurology, 248 (1): I3-I10, 2001.
  10. Matur, Z. and Parman, Y Botulinum toksininin n"orolojide kullanim alanlari. In Klinik Gelicsim, 23 (1): 121-127, 2010.
  11. TERZ.IOuGLU, A.; TUNCALI, D.; BARUTÇU, A. Y.; BAcSER, N. T. and ASLAN, G. Botulinum toksin A: Kozmetik uygulama ve literat"ur"un g"ozden geçirilmesi. In T"urk Plastik Rekonstr"uktif Ve Estetik Cerrahi Dergisi, 13 (3): 185-190, 2005.
  12. Small, R. Botulinum toxin injection for facial wrinkles. In American family physician, 90 (3): 168-175, 2014.
  13. Rohrich, R. J; Janis, J. E; Fagien, S. and Stuzin, J. M The cosmetic use of botulinum toxin. In Plastic and reconstructive surgery, 112 (5): 177S-188S, 2003.
  14. Kattimani, V.; Tiwari, R. V. C.; Gufran, K.; Wasan, B.; Shilpa, PH and Khader, A. A. Botulinum toxin application in facial esthetics and recent treatment indications (2013-2018). In Journal of International Society of Preventive & Community Dentistry, 9 (2): 99, 2019.
  15. Nestor, M.; Ablon, G. and Pickett, A. Key parameters for the use of abobotulinumtoxinA in aesthetics: onset and duration. In Aesthetic surgery journal, 37 (suppl_1): S20-S31, 2017.
  16. Bassichis, B. A and Thomas, J R. The use of Botox to treat glabellar rhytids. In Facial Plastic Surgery Clinics, 11 (4): 453-456, 2003.
  17. Jaspers, G.; Pijpe, J and Jansma, J The use of botulinum toxin type A in cosmetic facial procedures. In International journal of oral and maxillofacial surgery, 40 (2): 127-133, 2011.
  18. Ziade, M.; Domergue, S.; Batifol, D.; Jreige, R.; Sebbane, M.; Goudot, P. and Yachouh, J. Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study. In Journal of plastic, reconstructive & aesthetic surgery, 66 (2): 209-214, 2013.
  19. Qaqish, C. Botulinum toxin use in the upper face. In Atlas of the Oral and Maxillofacial Surgery Clinics of North America, 24 (2): 95-103, 2016.
  20. Comella, C. L; Jankovic, J. and Brin, M. F Use of botulinum toxin type A in the treatment of cervical dystonia. In Neurology, 55 (12 Suppl 5): S15-21, 2000.
  21. Ceballos-Baumann, A. O Evidence-based medicine in botulinum toxin therapy for cervical dystonia. In Journal of Neurology, 248 (1): I14-I20, 2001.
  22. KOCAMAN, G.; BASLO, M. B.; HANAuGASI, H. and PARMAN, Y. G. .Idyopatik Servikal Distonili Hastalarda Botulinum Toksini Uygulanmasindan "Once ve Sonra Kas Aktivasyon Paterninde G"or"ulen Deugicsimlerin .Incelenmesi. In Archives of Neuropsychiatry/Noropsikiatri Arsivi, 46 (2), 2009.
  23. Akin, Y. A.; Akbostanci, M. C.; Mercan, F. N.; Aksun, Z. and Sorgun, M. Botulinum Toksini Tedavisi Almics 118 Servikal Distonili Olgunun Retrospektif Deugerlendirmesi. In Journal of Neurology, 18: 104-7, 2012.
  24. Evidente, V. G. H and Pappert, E. J Botulinum toxin therapy for cervical dystonia: the science of dosing. In Tremor and Other Hyperkinetic Movements, 4, 2014.
  25. Rouientan, A.; Otaghvar, H. A.; Mahmoudvand, H. and Tizmaghz, A. Rare complication of botox injection: a case report. In World journal of plastic surgery, 8 (1): 116, 2019.
  26. Yi, Y. G.; Kim, K.; Yi, Y.; Choi, Y-A.; Leigh, J-H. and Bang, M. S. Botulinum toxin type A injection for cervical dystonia in adults with dyskinetic cerebral palsy. In Toxins, 10 (5): 203, 2018.
  27. Nijmeijer, S.; de Bruijn, E.; Verhagen, R; Forbes, PA; Kamphuis, DJ; Happee, R.; Tijssen, M. and Koelman, J. Spectral EMG changes in cervical dystonia patients and the influence of botulinum toxin treatment. In Toxins, 9 (9): 256, 2017.
  28. Huang, L; Chen, HX; Ding, XD; Xiao, HQ; Wang, W and Wang, H Efficacy analysis of ultrasound-guided local injection of botulinum toxin type A treatment with orthopedic joint brace in patients with cervical dystonia. In Eur. Rev. Med. Pharmacol. Sci, 19: 1989-1993, 2015.
  29. Jankovic, J.; Adler, C. H; Charles, D.; Comella, C.; Stacy, M.; Schwartz, M.; Adams, A. M. and Brin, M. F Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE). In Journal of the neurological sciences, 349 (1-2): 84-93, 2015.
  30. Yun, Ji Y.; Kim, J. W.; Kim, H-T.; Chung, S. Ju; Kim, J-M.; Cho, J. W.; Lee, J-Y.; Lee, Ha N.; You, S.; Oh, E. and thers, Dysport and Botox at a ratio of 2.5: 1 units in cervical dystonia: a double-blind, randomized study. In Movement Disorders, 30 (2): 206-213, 2015.
  31. Mordin, M.; Masaquel, C.; Abbott, C. and Copley-Merriman, C. Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study. In BMJ open, 4 (10): e005150, 2014.
  32. van den Dool, J.; Visser, B.; Koelman, J H.; Engelbert, R. HH and Tijssen, M. AJ Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial. In BMC neurology, 13 (1): 1-8, 2013.
  33. Coulon, JM Incobotulinumtoxin A (Xeomintextregistered) injected with flexible intervals is a well-tolerated long-term treatment of cervical dystonia. In Annals of Physical and Rehabilitation Medicine, 56: e398, 2013.
  34. Evidente, V. G. H; Fernandez, H. H; LeDoux, M. S; Brashear, A.; Grafe, S.; Hanschmann, A. and Comella, C. L A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomintextregistered) in cervical dystonia. In Journal of Neural Transmission, 120 (12): 1699-1707, 2013.
  35. Charles, D.; Brashear, A.; Hauser, R. A; Li, H-I.; Boo, L-M.; Brin, M. F; Group, CD 1. S. and thers, Efficacy, tolerability, and immunogenicity of onabotulinumtoxina in a randomized, double-blind, placebo-controlled trial for cervical dystonia. In Clinical neuropharmacology, 35 (5): 208-214, 2012.
  36. Comella, C. L; Jankovic, J.; Truong, D. D; Hanschmann, A.; Grafe, S.; Group, US X. C. D. S. and thers, Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMINtextregistered, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. In Journal of the neurological sciences, 308 (1-2): 103-109, 2011.
  37. Ranoux, D; Gury, C; Fondarai, J; Mas, JL and Zuber, M Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. In Journal of Neurology, Neurosurgery & Psychiatry, 72 (4): 459-462, 2002.
  38. Tilden, D. and Guarnieri, C. Cost-effectiveness of incobotulinumtoxin-A with flexible treatment intervals compared to onabotulinumtoxin-A in the management of blepharospasm and cervical dystonia. In Value in Health, 19 (2): 145-152, 2016.
  39. Scaglione, F. Conversion ratio between Botoxtextregistered, Dysporttextregistered, and Xeomintextregistered in clinical practice. In Toxins, 8 (3): 65, 2016.
  40. Han, Yi; Stevens, A. L; Dashtipour, K.; Hauser, R. A and Mari, Z. A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia. In Journal of Neurology, 263 (4): 772-780, 2016.
  41. Dressler, D.; Tacik, P. and Adib Saberi, F. Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botoxtextregistered) and incobotulinumtoxinA (Xeomintextregistered). In Journal of Neural Transmission, 121 (1): 29-31, 2014.
  42. Odergren, T; Hjaltason, H; Kaakkola, S.; Solders, G; Hanko, J; Fehling, C; Marttila, RJ; Lundh, H; Gedin, S; Westergren, I and thers, A double blind, randomised, parallel group study to investigate the dose equivalence of Dysporttextregistered and Botoxtextregistered in the treatment of cervical dystonia. In Journal of Neurology, Neurosurgery & Psychiatry, 64 (1): 6-12, 1998.
  43. Camfield, L; Ben-Shlomo, Y and Warner, TT Epidemiological study of Dystonia in Europe Collaborative Group impact of cervical dystonia on quality of life. In Mov Disord, 17 (4): 838-841, 2002.
  44. Queiroz, M. A. R.; Chien, H. F.; Sekeff-Sallem, F. A. and Barbosa, E. R. Physical therapy program for cervical dystonia: a study of 20 cases. In Functional neurology, 27 (3): 187, 2012.
  45. Bogey, R. A; Elovic, E. P; Bryant, P. R; Geis, C. C; Moroz, A. and O’Neill, B. J Rehabilitation of movement disorders. In Archives of physical medicine and rehabilitation, 85: 41-45, 2004.
  46. Tarsy, D. and Simon, D. K Dystonia. In New England Journal of Medicine, 355 (8): 818-829, 2006.
  47. Ramdharry, G. Physiotherapy cuts the dose of botulinum toxin. In Physiotherapy Research International, 11 (2): 117-122, 2006.
  48. Boyce, M. J; Canning, C. G; Mahant, N.; Morris, J.; Latimer, J. and Fung, V. SC Active exercise for individuals with cervical dystonia: a pilot randomized controlled trial. In Clinical rehabilitation, 27 (3): 226-235, 2013.
  49. Buccolieri, A.; Avanzino, L.; Marinelli, L.; Trompetto, C.; Marchese, R. and Abbruzzese, G. Muscle relaxation is impaired in dystonia: a reaction time study. In Movement disorders: official journal of the Movement Disorder Society, 19 (6): 681-687, 2004.
  50. Smania, N.; Corato, E.; Tinazzi, M.; Montagnana, B.; Fiaschi, A. and Aglioti, S. M The effect of two different rehabilitation treatments in cervical dystonia: preliminary results in four patients. In Functional neurology, 18 (4): 219-226, 2003.
  51. Tassorelli, C.; Mancini, F.; Balloni, L.; Pacchetti, C.; Sandrini, G.; Nappi, G. and Martignoni, E. Botulinum toxin and neuromotor rehabilitation: an integrated approach to idiopathic cervical dystonia. In Movement disorders: official journal of the Movement Disorder Society, 21 (12): 2240-2243, 2006.
  52. Tassorelli, C.; Mancini, F.; Balloni, L.; Pacchetti, C.; Sandrini, G.; Nappi, G. and Martignoni, E. Botulinum toxin and neuromotor rehabilitation: an integrated approach to idiopathic cervical dystonia. In Movement disorders: official journal of the Movement Disorder Society, 21 (12): 2240-2243, 2006.
  53. Zetterberg, L.; Halvorsen, K.; F"arnstrand, C.; Aquilonius, S-M. and Lindmark, B. Physiotherapy in cervical dystonia: six experimental single-case studies. In Physiotherapy theory and practice, 24 (4): 275-290, 2008.
  54. Queiroz, M. A. R.; Chien, H. F.; Sekeff-Sallem, F. A. and Barbosa, E. R. Physical therapy program for cervical dystonia: a study of 20 cases. In Functional neurology, 27 (3): 187, 2012.
  55. Queiroz, M. A. R.; Chien, H. F.; Sekeff-Sallem, F. A. and Barbosa, E. R. Physical therapy program for cervical dystonia: a study of 20 cases. In Functional neurology, 27 (3): 187, 2012.
  56. El-Bahrawy, M. N; El-Tamawy, M. S; Shalaby, N. M and Abdel-Alim, A. M Cervical dystonia: Abnormal head posture and its relation to hand function. In Egypt J Neurol, Psychiatr Neurosurg, 46: 203-208, 2009.
  57. Patel, N.; Jankovic, J. and Hallett, M. Sensory aspects of movement disorders. In The Lancet Neurology, 13 (1): 100-112, 2014.
  58. Kuyper, D. J; Parra, V.; Aerts, S.; Okun, M. S and Kluger, B. M Nonmotor manifestations of dystonia: a systematic review. In Movement Disorders, 26 (7): 1206-1217, 2011.
  59. Albanese, A.; Bhatia, K.; Bressman, S. B; DeLong, M. R; Fahn, S.; Fung, V. SC; Hallett, M.; Jankovic, J.; Jinnah, H. A; Klein, C. and thers, Phenomenology and classification of dystonia: a consensus update. In Movement disorders, 28 (7): 863-873, 2013.
  60. Gigante, AF; Berardelli, A and Defazio, G Rest tremor in idiopathic adult-onset dystonia. In European journal of neurology, 23 (5): 935-939, 2016.
  61. Albanese, A. and Del Sorbo, F. Dystonia and tremor: the clinical syndromes with isolated tremor. In Tremor and Other Hyperkinetic Movements, 6, 2016.
  62. Contarino, M. F.; Smit, M.; Van den Dool, J.; Volkmann, J. and Tijssen, M. AJ Unmet needs in the management of cervical dystonia. In Frontiers in neurology, 7: 165, 2016.